Ultrasound waves of scaled intensity and frequency have shown promise in breaking apart...
- Targeted ultrasound kills cancer cells while sparing healthy ones
- Haemoglobin spray could cut NHS chronic wound care costs, study finds
- Dreem team: insomnia therapy goes hi-tech
- Robotic thread could treat stroke and other brain blockages
- Snooze, you lose: the devices helping to understand the science of sleep
Mauna Kea gets FDA approval for Cellvizio with fluorescein dye
Mauna Kea Technologies, France has secured the US Food and Drug Administration (FDA) 510(k) approval for Cellvizio 100 series and all associated Confocal Miniprobes for visualisation of blood flow when used with drug combination fluorescein.
GI Dynamics enrols first patient in US STEP-1 trial of EndoBarrier
Medical devices developer GI Dynamics has announced that the US STEP-1 clinical trial has enrolled the first patient of its EndoBarrier implant.
GammaTile therapy cleared for newly diagnosed malignant tumours
Brain tumour therapy company GT Medical Technologies has received US Food and Drug Administration clearance for an expanded indication of its GammaTile therapy.
Neovasc to develop Tiara system to treat mitral valve disease
Neovasc has an advanced new transfemoral trans-septal Tiara (TF / TS Tiara) design concept after carrying out successful acute animal tests to develop a device to treat patients with severe mitral valve regurgitation.
Abbott secures expanded FDA approval for Infinity DBS System
Medical devices maker Abbott Laboratories has secured approval from the US Food and Drug Administration (FDA) for its Infinity Deep Brain Stimulation (DBS) system to treat Parkinson’s disease.
Smith+Nephew acquires Tusker Medical to expand ENT portfolio
UK-based medical equipment manufacturer Smith+Nephew has acquired Tusker Medical for an undisclosed amount.
Greiner Bio-One Supports the Swiss Red Cross in Lebanon
Greiner Bio-One is supporting a Swiss Red Cross (SRK) project to modernise the blood donor service and the provision of safe blood supplies for Syrian refugees and the wider public in Lebanon.
Medtronic secures FDA approval for PulseSelect PFA system trial
Medtronic has secured approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) trial to assess PulseSelect pulsed-field ablation (PFA) system that employs pulsed electric fields to treat atrial fibrillation.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.